Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
Cancer immunotherapy, which stimulates or augments host immune responses to treat malignancies, is the latest development in the rapidly advancing field of cancer immunology. The basic principles of immunotherapies are either to enhance the functions of specific components of the immune system or to...
Main Authors: | Fokhrul Hossain, Samarpan Majumder, Deniz A. Ucar, Paulo C. Rodriguez, Todd E. Golde, Lisa M. Minter, Barbara A. Osborne, Lucio Miele |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01288/full |
Similar Items
-
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01) -
Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer
by: Fokhrul Hossain, et al.
Published: (2021-10-01) -
The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer
by: Michele Vigolo, et al.
Published: (2023-08-01) -
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses
by: Giulia Monticone, et al.
Published: (2022-08-01) -
Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways
by: Fokhrul Hossain, et al.
Published: (2018-12-01)